Cargando…

Deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the β-catenin destruction complex

Intrahepatic cholestasis induced by drug toxicity may cause cholestatic hepatic injury (CHI) leading to liver fibrosis and cirrhosis. The G protein-coupled bile acid receptor 1 (TGR5) is a membrane receptor with well-known roles in the regulation of glucose metabolism and energy homeostasis. However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Jianhua, Yang, Chao, Yang, Shikun, Lu, Hao, Hu, Yuanchang, Lu, Ling, Cheng, Feng, Wang, Xuehao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206975/ https://www.ncbi.nlm.nih.gov/pubmed/31930324 http://dx.doi.org/10.1093/intimm/dxaa002

Ejemplares similares

Corrigendum to: Deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the β-catenin destruction complex
por: Rao, Jianhua, et al.
Publicado: (2021)

Hyperglycemia-triggered ATF6-CHOP pathway aggravates acute inflammatory liver injury by β-catenin signaling
por: Yang, Chao, et al.
Publicado: (2022)

miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9
por: Yang, Chao, et al.
Publicado: (2017)

Retraction Note: miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9
por: Yang, Chao, et al.
Publicado: (2023)

RETRACTED ARTICLE: miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB
por: Hu, Yuanchang, et al.
Publicado: (2018)

Retraction Note to: miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB
por: Hu, Yuanchang, et al.
Publicado: (2023)

Hyperglycemia‐Triggered Sphingosine‐1‐Phosphate and Sphingosine‐1‐Phosphate Receptor 3 Signaling Worsens Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization
por: Hu, Yuanchang, et al.
Publicado: (2019)

Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway
por: Yang, Shikun, et al.
Publicado: (2018)

Nogo-B is a key mediator of hepatic ischemia and reperfusion injury
por: Rao, Jianhua, et al.
Publicado: (2020)

Epigenetically modulated miR-1224 suppresses the proliferation of HCC through CREB-mediated activation of YAP signaling pathway
por: Yang, Shikun, et al.
Publicado: (2021)

TGR5 Signaling in Hepatic Metabolic Health
por: Holter, Marlena M., et al.
Publicado: (2020)

TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathway
por: Yang, Haojun, et al.
Publicado: (2021)

Myeloid β-Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
por: Wang, Fang, et al.
Publicado: (2018)

Cholestatic hepatitis with intravenous ceftriaxone
por: Kaur, Inderpal, et al.
Publicado: (2011)

Azathioprine induced cholestatic hepatitis
por: Moses, Viju, et al.
Publicado: (2011)

Azithromycin-induced cholestatic hepatitis
por: Koffas, Apostolos, et al.
Publicado: (2017)

Inhibition of CBP/β‐catenin signaling ameliorated fibrosis in cholestatic liver disease
por: Kimura, Masamichi, et al.
Publicado: (2022)

Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment
por: Yang, Wenjie, et al.
Publicado: (2020)

TGR5 deficiency aggravates hepatic ischemic/reperfusion injury via inhibiting SIRT3/FOXO3/HIF-1ɑ pathway
por: Wang, Qi, et al.
Publicado: (2020)

Cholestatic hepatitis due to Salmonella typhi
por: Albayrak, Ayse, et al.
Publicado: (2011)

Echinacea-associated acute cholestatic hepatitis
por: Gabranis, I, et al.
Publicado: (2015)

Mechanisms of Hepatic Cholestatic Drug Injury
por: Kolarić, Tea Omanović, et al.
Publicado: (2019)

Hepatocyte specific expression of an oncogenic variant of β-catenin results in cholestatic liver disease
por: Lemberger, Ursula J., et al.
Publicado: (2016)

Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance
por: Qiao, Lu, et al.
Publicado: (2022)

Loss of α-catenin elicits a cholestatic response and impairs liver regeneration
por: Herr, Keira Joann, et al.
Publicado: (2014)

Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
por: Ozkan, Tanju Basarir, et al.
Publicado: (2007)

Carbimazole-induced cholestatic hepatitis in Graves’ disease
por: Kota, Sunil K., et al.
Publicado: (2013)

Nafcillin-Induced Allergic Eosinophilic Cholestatic Hepatitis
por: Guido, Mark V., et al.
Publicado: (2017)

Giant Cell Arteritis Presenting as Cholestatic Hepatitis
por: Riordan, Gerald, et al.
Publicado: (2021)

Keratin 7 expression in hepatic cholestatic diseases
por: Sakellariou, S., et al.
Publicado: (2021)

Tozinameran: Severe cholestatic hepatitis: case report
Publicado: (2021)

TGR5 expression in normal kidney and renal neoplasms
por: Zhao, Chaohui Lisa, et al.
Publicado: (2018)

Cephalexin Induced Cholestatic Jaundice
por: Agrawal, Abhinav, et al.
Publicado: (2014)

Fibrosing cholestatic hepatitis: a report of three cases.
por: Lee, H. K., et al.
Publicado: (2000)

Cholestatic Hepatitis and Thrombocytosis in a Secondary Syphilis Patient
por: Kim, Gi Hyun, et al.
Publicado: (2010)

Cholestatic Hepatitis with Small Duct Injury Associated with Celecoxib
por: Nayudu, Suresh Kumar, et al.
Publicado: (2013)

Cholestatic Hepatitis in Graves' Disease: A Diagnostic Challenge
por: Haddaden, Metri, et al.
Publicado: (2021)

Epstein-Barr Virus Reactivation Causing Cholestatic Hepatitis
por: Da Cunha, Teresa, et al.
Publicado: (2022)

The oncogene Mct-1 promotes progression of hepatocellular carcinoma via enhancement of Yap-mediated cell proliferation
por: Yang, Wenjie, et al.
Publicado: (2021)

Molecular regulation and pharmacological targeting of the β‐catenin destruction complex
por: van Kappel, Eline C, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ijae6hnnl4ci2u1u7o6qav5g4n